Wegovy augments our already existing GLP-1 that leads to decreased hunger, increased fullness and delayed stomach emptying of food, she explains
As of March 31, 2024, the FDA received 442 adverse event reports related to compounded semaglutide, including 319 serious cases, 99 hospitalizations, and 7 deaths
He has also served on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co., Menarini/Berlin Chemie, Merck, Sharp & Dohme, Novo Nordisk, and Sun Pharma
Because of this potential risk, there is a formal warning on the medication
Now that we know semaglutide works for weight loss as well as diabetes, its already become very popular and were seeing semaglutide shortages in several countries
Any transition should be guided by a qualified healthcare professional